BLC
MRK icon

Brown, Lisle/Cummings’s Merck MRK Stock Holding History

Brown, Lisle/Cummings’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
33,055
-18
-0.1% -$2.11K 0.95% 24
2026
Q1 		$3.98M Buy
33,073
+186
+0.6% +$21.5K 0.99% 24
2025
Q4 		$3.46M Buy
32,887
+227
+0.7% +$21.3K 0.85% 31
2025
Q3 		$2.74M Sell
32,660
-425
-1% -$35K 0.7% 38
2025
Q2 		$2.62M Sell
33,085
-2,330
-7% -$185K 0.7% 40
2025
Q1 		$3.18M Buy
35,415
+1,233
+4% +$115K 0.92% 28
2024
Q4 		$3.4M Buy
34,182
+1,995
+6% +$206K 1.01% 24
2024
Q3 		$3.66M Buy
32,187
+1,250
+4% +$149K 1.11% 23
2024
Q2 		$3.83M Buy
30,937
+2,074
+7% +$267K 1.25% 19
2024
Q1 		$3.81M Sell
28,863
-25
-0.1% -$3.08K 1.29% 20
2023
Q4 		$3.15M Buy
28,888
+8,974
+45% +$932K 1.17% 22
2023
Q3 		$2.05M Buy
19,914
+419
+2% +$45.2K 0.93% 26
2023
Q2 		$2.25M Buy
19,495
+2,895
+17% +$329K 1.01% 23
2023
Q1 		$1.77M Sell
16,600
-960
-5% -$104K 0.9% 27
2022
Q4 		$1.95M Buy
17,560
+548
+3% +$56K 1.05% 25
2022
Q3 		$1.47M Buy
17,012
+100
+0.6% +$8.93K 0.86% 32
2022
Q2 		$1.54M Sell
16,912
-657
-4% -$58.2K 0.85% 32
2022
Q1 		$1.44M Buy
17,569
+320
+2% +$25.2K 0.69% 39
2021
Q4 		$1.32M Buy
+17,249
New +$1.37M 0.66% 41

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown, Lisle/Cummings's MRK Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Merck (MRK) stake by 0.05% in Q2 2026, selling an estimated $2.11K and leaving 33,055 shares worth $4.25M. The position accounts for 0.95% of the portfolio, ranked #24.

Brown, Lisle/Cummings first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brown, Lisle/Cummings held 33,055 shares of Merck worth $4.25M as of Q2 2026.
  • Brown, Lisle/Cummings sold 18 Merck shares in Q2 2026, an estimated $2.11K.
  • Merck made up 0.95% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #24 holding.
  • Brown, Lisle/Cummings first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.